s.grahame
TL2 Member · Quebec City, CA
Practical questions, practical answers. Not interested in speculation without a source.
Joined 14 December 2024 · last posted 3d
83 posts, newest first. Showing up to 150.
-
Coming back to: A structured critique template this community uses Replied, post #68 · Evidence › Study critique · 25 Jul 2026 · 7 likes On post #64 — agreed on the reasoning, with one qualification. What makes a methodological criticism substantive: it identifies a specific feature of the design that…
-
What a reversed-phase purity number actually is Replied, post #81 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 2 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Here for the analytics and not much else Replied, post #55 · Lounge › Introductions · 19 Jul 2026 · 6 likes This follows post #52 rather than contradicting it. What to include: your name or handle, how you found the community, what brings you here, maybe something about…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #88 · Access › International · 17 Jul 2026 · 7 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
What a reversed-phase purity number actually is Replied, post #62 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #76 · Analytics › Home & field testing · 14 Jul 2026 · 5 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #80 · Sourcing › Red flags · 13 Jul 2026 · 31 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Aggregate verification data across the directory, with caveats Replied, post #43 · Sourcing › Independent verification · 12 Jul 2026 · 23 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #49 · Clinical › Bloodwork · 27 Jun 2026 · 0 likes Picking up post #46: that is the part I would want checked first. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
Revisiting: What pooling buys you and what it destroys Replied, post #69 · Evidence › Meta-analyses · 26 Jun 2026 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #101 · Sourcing › Logistics · 14 Jun 2026 · 1 like Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Batch numbers that do not match the vial label Replied, post #21 · Sourcing › Red flags · 27 May 2026 · 19 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
About the COA interpretation category Replied, post #11 · Analytics › COA interpretation · 11 May 2026 · 28 likes Worth separating two things that post #7 runs together. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #17 · Sourcing › Logistics · 26 Apr 2026 · 0 likes post #16 answers the question as asked. The question underneath it is different. Customs holds: if a parcel is held at customs and you can contact customs directly,…
-
Run-in periods and the population they select Replied, post #81 · Evidence › Trials · 13 Mar 2026 · 25 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #32 · Sourcing › Vendor reports · 7 Mar 2026 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Contributing data without breaching anyone's privacy Replied, post #69 · Data & Tools › Datasets · 6 Mar 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] What a purity-only report leaves out Replied, post #41 · Sourcing › Independent verification · 2 Mar 2026 · 0 likes Worth separating two things that post #37 runs together. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #85 · Practice › Dosing & titration · 19 Feb 2026 · 9 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #41 · Analytics › Impurities & related substances · 9 Feb 2026 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
PCOS and metabolic overlap: what is and is not studied Started this topic · Clinical › Comorbidities · 6 Feb 2026 · 0 likes On the subject in the title: PCOS and metabolic overlap: what is and is not studied Working notes rather than a conclusion. Asking about a population rather than about…
-
Endotoxin and why it is a separate question from purity Replied, post #2 · Analytics › Impurities & related substances · 5 Feb 2026 · 23 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #4 · Practice › Side effects · 12 Jan 2026 · 8 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #43 · Regional › UK & Ireland · 6 Jan 2026 · 5 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #15 · Practice › Interactions · 29 Dec 2025 · 14 likes On post #11 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #25 · Practice › Interactions · 25 Dec 2025 · 3 likes Picking up post #22: that is the part I would want checked first. Separation timing versus clinically important interaction: a separation timing inconvenience (taking…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #44 · Sourcing › Independent verification · 15 Dec 2025 · 16 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #30 · Compounds › Tirzepatide · 12 Dec 2025 · 21 likes On post #26 — agreed on the reasoning, with one qualification. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect…
-
Documentation that materially improves an appeal's chances Replied, post #91 · Access › Insurance & coverage · 5 Dec 2025 · 17 likes Picking up post #88: that is the part I would want checked first. Documentation your clinician can provide: letters from clinicians describing why standard treatments…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #32 · Practice › Side effects · 22 Nov 2025 · 15 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #9 · Compounds › Tirzepatide · 21 Nov 2025 · 0 likes This follows post #6 rather than contradicting it. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady…
-
Pen dose counters: what a click does and does not guarantee Replied, post #7 · Devices › Pens & autoinjectors · 12 Nov 2025 · 1 like Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Appeal templates and why they are deliberately unemotional Replied, post #22 · Access › Insurance & coverage · 11 Nov 2025 · 6 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #4 · Compounds › Tirzepatide · 3 Nov 2025 · 5 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Sleep tracking data and its considerable limitations Replied, post #66 · Wellbeing › Sleep · 23 Oct 2025 · 0 likes This follows post #63 rather than contradicting it. Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing…
-
Amylin receptor signalling and satiety Started this topic · Pharmacology › Receptor biology · 17 Oct 2025 · 3 likes Amylin receptor signalling and satiety Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an…
-
Follow-up: Why appetite effects are mostly central Replied, post #69 · Pharmacology › Receptor biology · 17 Oct 2025 · 14 likes post #68 is right about the mechanism and I think understates the practical bit. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress…
-
Research-use-only labelling: what it means and what it does not Replied, post #43 · Sourcing › Regulatory · 8 Oct 2025 · 21 likes This follows post #40 rather than contradicting it. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #6 · Compounds › Retatrutide · 6 Oct 2025 · 12 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Second pass at: Coverage in the US: a map of the usual obstacles Replied, post #4 · Regional › North America · 6 Oct 2025 · 0 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Column chemistry choices for a 40-residue peptide Replied, post #41 · Analytics › HPLC & UHPLC · 20 Sep 2025 · 0 likes On post #37 — agreed on the reasoning, with one qualification. This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #49 · Evidence › Study critique · 14 Sep 2025 · 12 likes Coming back to post #47, because the follow-up matters more than the original answer. Bias towards the null and bias away from the null: different criticisms have…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #34 · Lounge › Off topic · 13 Sep 2025 · 0 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Hepatic impairment and the absence of data Replied, post #33 · Clinical › Special populations · 13 Sep 2025 · 24 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
When a preprint is the best available evidence and we say so Replied, post #136 · Evidence › Preprints · 3 Sep 2025 · 0 likes Worth separating two things that post #132 runs together. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #40 · Sourcing › Regulatory · 1 Sep 2025 · 15 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #110 · Compounds › Secretagogues & GH axis · 29 Aug 2025 · 5 likes Coming back to post #108, because the follow-up matters more than the original answer. IGF-1 as a surrogate: it is a better integrated measure than a spot growth…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #88 · Access › Insurance & coverage · 21 Aug 2025 · 5 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #36 · Sourcing › Vendor reports · 7 Aug 2025 · 0 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #2 · Evidence › Journal club · 5 Aug 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
-
A ten-fold dose error caught before injection — one year on Replied, post #114 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes Coming back to post #112, because the follow-up matters more than the original answer. Dead volume: residual liquid in the hub and needle after withdrawal. Typical…
-
Thyroid function tests during substantial weight change Replied, post #18 · Clinical › Bloodwork · 31 Jul 2025 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Subcutaneous absorption kinetics and site differences Replied, post #17 · Pharmacology › Pharmacokinetics · 22 Jul 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #60 · Evidence › Trials · 23 Jun 2025 · 6 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
What a documentation review can and cannot tell you Replied, post #6 · Sourcing › Independent verification · 15 Jun 2025 · 31 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #45 · Evidence › Journal club · 25 May 2025 · 32 likes Picking up post #42: that is the part I would want checked first. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #44 · Sourcing › Independent verification · 21 May 2025 · 4 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
A ten-fold dose error caught before injection Replied, post #25 · Devices › Syringes & needles · 24 Apr 2025 · 22 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #60 · Access › Pricing · 9 Apr 2025 · 25 likes On post #56 — agreed on the reasoning, with one qualification. Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if…
-
Carryover and the ghost peak from last week's standard Replied, post #37 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 2 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
A report I filed that turned out to be wrong, and the correction Replied, post #4 · Sourcing › Vendor reports · 4 Apr 2025 · 1 like What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #89 · Evidence › Journal club · 2 Apr 2025 · 9 likes Coming back to post #87, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Started this topic · Evidence › Trials · 22 Mar 2025 · 39 likes Comparators chosen for regulatory reasons rather than clinical ones — one year on — setting out what I have, and where I think it stops being reliable. Session topic:…
-
The C-cell question: rodent findings and their human context Started this topic · Compounds › Semaglutide · 13 Mar 2025 · 0 likes Posting this under the heading it deserves: The C-cell question: rodent findings and their human context Everything below is what sits behind that. I have seen STEP 8 (…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #88 · Pharmacology › Receptor biology · 13 Mar 2025 · 17 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #5 · Practice › Reconstitution · 27 Jan 2025 · 13 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #57 · Analytics › COA interpretation · 25 Jan 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
When "no data" is the complete and final answer Replied, post #72 · Compounds › Other compounds · 22 Jan 2025 · 7 likes This follows post #69 rather than contradicting it. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #34 · Compounds › Semaglutide · 21 Jan 2025 · 8 likes post #33 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Swirling versus inverting versus leaving it alone Replied, post #3 · Practice › Reconstitution · 15 Jan 2025 · 5 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Fixed versus detachable needles: the trade-offs Replied, post #61 · Devices › Syringes & needles · 20 Dec 2024 · 13 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
People with a low starting BMI: where the evidence stops Replied, post #20 · Clinical › Special populations · 2 Dec 2024 · 0 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #138 · Compounds › Repair & healing peptides · 24 Nov 2024 · 3 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #17 · Nutrition & Training › Protein & intake · 23 Nov 2024 · 2 likes I read post #15 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Requesting a page: what makes a good request — what changed since Replied, post #42 · Documentation › Wiki requests · 10 Oct 2024 · 2 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #46 · Compounds › Semaglutide · 11 Sep 2024 · 18 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #10 · Compounds › Retatrutide · 30 Aug 2024 · 14 likes On post #6 — agreed on the reasoning, with one qualification. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #23 · Devices › Syringes & needles · 19 Aug 2024 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #5 · Compounds › Secretagogues & GH axis · 14 Aug 2024 · 3 likes I read post #3 twice before replying, because I had assumed the opposite. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #21 · Clinical › Prescriber conversations · 16 Jul 2024 · 4 likes Picking up post #18: that is the part I would want checked first. Asking about monitoring: understand what lab work will be done, how often, and what you will be…
-
The mass-error checker and its intended scope Replied, post #100 · Data & Tools › Calculators · 5 Jul 2024 · 10 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
How this community labels and discusses unrefereed work Replied, post #33 · Evidence › Preprints · 22 Jun 2024 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Assessing a warm arrival: the decision process — one year on Replied, post #32 · Sourcing › Logistics · 29 May 2024 · 2 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…